Lung Cancer Specimen Repository Protocol, Ancillary

For patients enrolled to and eligible for the following Southwest Oncology Group coordinated lung cancer treatment protocols: SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9509, S9900, S0003, S0023, S0126, S0124, S0220, S0222, S0327, S0339, S0310, S0342, S0341, S0435, S0509, S0429, S0526, S0533, and S0536. Patients subsequently found to be ineligible for the therapeutic protocol to which they are registered will be declared ineligible for this protocol. Patients must submit specimens for this study as defined for the respective treatment study in Sections 4.0 (General) and 10.0 (Specific). The adequacy of the tissue specimen will be determined at the time the specimen arrives at the Repository. Minimum requirements for this study may be found in Appendix 10.0 of the protocol. Consent for specimen submission will be obtained and documented with consent for the appropriate treatment protocol.

This study has been approved by NCI's Central Institutional Review Board.